Joincare Pharmaceutical Group Industry Co.,Ltd. (SHA:600380)
China · Delayed Price · Currency is CNY 10.53
+0.04 (0.38%)
Nov 6, 2026, 3:00 PM CST
SHA:600380 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 11,815 | 13,611 | 14,852 | 15,692 | 14,808 | 11,729 |
Short-Term Investments | 445.4 | 880.84 | 556.41 | 406.38 | 54.05 | - |
Trading Asset Securities | 68.13 | 1,694 | 89.36 | 82.9 | 109.02 | 184.64 |
Cash & Short-Term Investments | 12,329 | 16,186 | 15,498 | 16,181 | 14,972 | 11,914 |
Cash Growth | -25.48% | 4.44% | -4.22% | 8.08% | 25.66% | -3.28% |
Accounts Receivable | 3,364 | 4,359 | 4,381 | 4,634 | 5,064 | 4,831 |
Other Receivables | 114.02 | 69.36 | 51.17 | 46.01 | 52.54 | 88.05 |
Receivables | 3,478 | 4,428 | 4,432 | 4,680 | 5,116 | 4,919 |
Inventory | 2,404 | 2,214 | 2,621 | 2,656 | 2,562 | 2,079 |
Other Current Assets | 663.88 | 332.59 | 454.5 | 357.51 | 527.81 | 453.22 |
Total Current Assets | 18,874 | 23,160 | 23,006 | 23,875 | 23,178 | 19,365 |
Property, Plant & Equipment | 6,358 | 6,081 | 6,259 | 6,193 | 6,118 | 5,629 |
Long-Term Investments | 5,131 | 2,971 | 3,531 | 3,206 | 3,426 | 2,880 |
Goodwill | 1,606 | 636.34 | 636.34 | 636.34 | 614.47 | 614.47 |
Other Intangible Assets | 817.76 | 885.7 | 687.43 | 683.34 | 802.12 | 456.78 |
Long-Term Accounts Receivable | - | - | - | - | - | 0.27 |
Long-Term Deferred Tax Assets | 873.67 | 822.67 | 685.47 | 579.53 | 540.04 | 552.54 |
Long-Term Deferred Charges | 752.8 | 364.88 | 362.7 | 483.49 | 428.28 | 786.99 |
Other Long-Term Assets | 247.29 | 493.29 | 549.95 | 702.25 | 628.27 | 818.36 |
Total Assets | 34,660 | 35,414 | 35,718 | 36,358 | 35,735 | 31,104 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1,736 | 1,987 | 2,150 | 2,363 | 2,580 | 2,454 |
Accrued Expenses | 331.54 | 3,767 | 3,685 | 3,947 | 4,178 | 3,749 |
Short-Term Debt | 3,667 | 2,240 | 2,455 | 2,076 | 2,126 | 2,518 |
Current Portion of Long-Term Debt | 94.4 | 351.63 | 376.17 | 696.48 | 43.66 | 70.28 |
Current Portion of Leases | - | 186.38 | 210.34 | 214.93 | 19.42 | 21.3 |
Current Income Taxes Payable | 234.02 | 100.95 | 150.51 | 248.97 | 124.04 | 145.11 |
Current Unearned Revenue | 75.35 | 121.57 | 142.4 | 159.08 | 292.98 | 234.14 |
Other Current Liabilities | 4,382 | 101.47 | 100.74 | 154.29 | 390.77 | 160.17 |
Total Current Liabilities | 10,521 | 8,856 | 9,271 | 9,861 | 9,755 | 9,352 |
Long-Term Debt | 943.81 | 1,572 | 2,425 | 3,122 | 3,231 | 826.78 |
Long-Term Leases | 25.7 | 21.91 | 19.98 | 15.42 | 23.48 | 25.07 |
Long-Term Unearned Revenue | 325.29 | 327.84 | 334.97 | 370.18 | 384.54 | 433.54 |
Long-Term Deferred Tax Liabilities | 300.71 | 268.22 | 267.62 | 260.03 | 237.19 | 208.53 |
Other Long-Term Liabilities | 5.5 | - | - | 90 | 84 | 78 |
Total Liabilities | 12,122 | 11,046 | 12,318 | 13,719 | 13,715 | 10,924 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1,829 | 1,829 | 1,874 | 1,866 | 1,929 | 1,908 |
Additional Paid-In Capital | - | 663.25 | 1,175 | 1,352 | 2,222 | 2,153 |
Retained Earnings | 11,529 | 12,343 | 11,376 | 10,301 | 9,192 | 7,864 |
Treasury Stock | - | - | -328.22 | - | -347.18 | -222.64 |
Comprehensive Income & Other | 926.81 | 344.35 | 437.84 | 237.07 | 126.72 | 117.88 |
Total Common Equity | 14,286 | 15,180 | 14,535 | 13,756 | 13,122 | 11,820 |
Minority Interest | 8,253 | 9,189 | 8,865 | 8,884 | 8,898 | 8,359 |
Shareholders' Equity | 22,539 | 24,368 | 23,400 | 22,640 | 22,020 | 20,180 |
Total Liabilities & Equity | 34,660 | 35,414 | 35,718 | 36,358 | 35,735 | 31,104 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 4,731 | 4,372 | 5,486 | 6,125 | 5,443 | 3,462 |
Net Cash (Debt) | 7,597 | 11,813 | 10,012 | 10,056 | 9,528 | 8,452 |
Net Cash Growth | -33.06% | 18.00% | -0.44% | 5.54% | 12.73% | -14.00% |
Net Cash Per Share | 4.11 | 6.46 | 5.34 | 5.30 | 5.02 | 4.36 |
Filing Date Shares Outstanding | 1,829 | 1,829 | 1,845 | 1,866 | 1,928 | 1,890 |
Total Common Shares Outstanding | 1,829 | 1,829 | 1,845 | 1,866 | 1,928 | 1,890 |
Working Capital | 8,353 | 14,304 | 13,735 | 14,014 | 13,423 | 10,013 |
Book Value Per Share | 7.81 | 8.30 | 7.88 | 7.37 | 6.81 | 6.25 |
Tangible Book Value | 11,862 | 13,658 | 13,211 | 12,436 | 11,705 | 10,749 |
Tangible Book Value Per Share | 6.48 | 7.47 | 7.16 | 6.67 | 6.07 | 5.69 |
Buildings | - | 4,871 | 4,825 | 4,619 | 4,279 | 3,950 |
Machinery | - | 7,798 | 7,534 | 7,108 | 6,524 | 5,928 |
Construction In Progress | - | 615.35 | 531.06 | 531.06 | 811.3 | 743 |